ReviewFrontiers in medicine2022

NR4A1-3 nuclear receptor activity and immune cell dysregulation in rheumatic diseases.

Evelyn P Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.